XCath EVR robotic system performs first-in-human brain aneurysm procedures
Evidence notes
- XCath announced first-in-human use of its EVR robotic system to treat three patients with complex brain aneurysms at The Panama Clinic.
- The procedures marked only the second time a surgical robot had been used in an intracranial neurovascular intervention.
- The milestone established a major clinical proof point ahead of commercialization and later Series C financing.
Company context
Develops neuro-endovascular surgical robotics and steerable guidewire systems for minimally invasive treatment of cerebrovascular conditions including stroke and brain aneurysms. The company's platform is designed to improve precision and consistency in complex vascular navigation and expand access to neurovascular intervention.